Cargando…
Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice
Making provocative headlines, three outstanding publications demonstrated that early-life treatment with rapamycin, including treatments during developmental growth, extends lifespan in animals, confirming predictions of hyperfunction theory, which views aging as a quasi-program (an unintended conti...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648808/ https://www.ncbi.nlm.nih.gov/pubmed/36332147 http://dx.doi.org/10.18632/aging.204354 |